Total serum magnesium in the icteric neonates before and after phototherapy

Evaluation of total serum magnesium concentrations in neonatal hyperbilirubinemia before and after phototherapy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015090823942N1

Enrollment

Registered

2016-03-22

Start date

2010-04-04

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal jaundice. Physiological jaundice (intense)(prolonged) NOS

Interventions

Intervention group: The breast-fed newborns with exaggerated Bilirubin levels and those for whom initial managements could not decline increasing Bilirubin loads, phototherapy was employed based on th

Treatment - Other

Eligibility

Sex/Gender

All

Age

1 Days to 15 Days

Inclusion criteria

Inclusion criteria: Inclusion criteria: 90 otherwise-healthy term newborns with nonhemolytic hyperbilirubinemia during the first 4 weeks of life according to their age and standard graphs Exclusion criteria:Those neonates with anemia(Hb<8 ); symptoms in favor of hemolysis (ABO or Rh mismatch, G6PD deficiency, positive direct coombs test); history of Mg sulfate administration in mother and symptoms/signs in favor of infections; metabolic and endocrine disorders

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Total serum bilirubin. Timepoint: Before and after phototherapy. Method of measurement: Spectrophotometry.	—

Secondary

Measure	Time frame
Total serum magnesium. Timepoint: Before and after phototherapy. Method of measurement: Atomic absorption.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Shiri

Razi hospital, Department of Dermatology, Tehran University of Medical Sciences

msh.iums@gmail.com+98 21 5560 9951

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026